BIOHIT HealthCare will be launching its GastroPanel Quick Test at BSG LIVE’23, which will take place from 19-22 June at the Arena and Conference Centre (ACC) Liverpool. This annual meeting provides the ideal opportunity to share this innovation with colleagues in the gastroenterology and hepatology community, as they come together to discuss the latest advances in the field.
GastroPanel Quick Test is a revolutionary approach to the diagnosis of Helicobacter pylori infection, atrophic gastritis and high acid outputs in both symptomatic and asymptomatic patients. The rapid, non-invasive test investigates H. pylori infection and three stomach-specific biomarkers – pepsinogen I, pepsinogen II and gastrin-17 – in just 15 minutes. This can help clinicians to send patients for endoscopy sooner and at a fraction of the cost, promoting earlier cancer discovery and intervention through surveillance programmes.
BIOHIT HealthCare’s many unique and patented diagnostic tests transform clinical practice and make screening, diagnosis and monitoring of gastrointestinal diseases efficient and cost effective. Non-invasive diagnostics are at the core of BIOHIT's offering, making it the provider of choice for leading gastroenterologists and laboratory scientists worldwide.
